<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2021, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 29 Mar 2018 06:30:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>MediciNova Announces Results of Phase 2 Clinical Trial of MN-166 (ibudilast) in Methamphetamine Dependence</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Results+of+Phase+2+Clinical+Trial+of+MN-166+%28ibudilast%29+in+Methamphetamine+Dependence/13997798.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Results+of+Phase+2+Clinical+Trial+of+MN-166+%28ibudilast%29+in+Methamphetamine+Dependence/13997798.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Results+of+Phase+2+Clinical+Trial+of+MN-166+%28ibudilast%29+in+Methamphetamine+Dependence/13997798.html</guid>
   <pubDate>Thu, 29 Mar 2018 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24633582</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Results of Phase 2 Clinical Trial of MN-166 (ibudilast) in Methamphetamine Dependence</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Results+of+Phase+2+Clinical+Trial+of+MN-166+%28ibudilast%29+in+Methamphetamine+Dependence/13997798.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Results+of+Phase+2+Clinical+Trial+of+MN-166+%28ibudilast%29+in+Methamphetamine+Dependence/13997798.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Results+of+Phase+2+Clinical+Trial+of+MN-166+%28ibudilast%29+in+Methamphetamine+Dependence/13997798.html</guid>
   <pubDate>Thu, 29 Mar 2018 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24633582</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Results of Phase 2 Clinical Trial of MN-166 (ibudilast) in Methamphetamine Dependence</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Results+of+Phase+2+Clinical+Trial+of+MN-166+%28ibudilast%29+in+Methamphetamine+Dependence/13997798.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Results+of+Phase+2+Clinical+Trial+of+MN-166+%28ibudilast%29+in+Methamphetamine+Dependence/13997798.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Results+of+Phase+2+Clinical+Trial+of+MN-166+%28ibudilast%29+in+Methamphetamine+Dependence/13997798.html</guid>
   <pubDate>Thu, 29 Mar 2018 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24633582</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Collaboration with the University of Sydney Concord Cancer Centre to Evaluate MN-166 (ibudilast) in Chemotherapy-Induced Peripheral Neuropathy</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Collaboration+with+the+University+of+Sydney+Concord+Cancer+Centre+to+Evaluate+MN-166+%28ibudilast%29+in+Chemotherapy-Induced+Peripheral+Neuropathy/13996801.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Collaboration+with+the+University+of+Sydney+Concord+Cancer+Centre+to+Evaluate+MN-166+%28ibudilast%29+in+Chemotherapy-Induced+Peripheral+Neuropathy/13996801.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Collaboration+with+the+University+of+Sydney+Concord+Cancer+Centre+to+Evaluate+MN-166+%28ibudilast%29+in+Chemotherapy-Induced+Peripheral+Neuropathy/13996801.html</guid>
   <pubDate>Wed, 28 Mar 2018 19:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20576704</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39429199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Collaboration with the University of Sydney Concord Cancer Centre to Evaluate MN-166 (ibudilast) in Chemotherapy-Induced Peripheral Neuropathy</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Collaboration+with+the+University+of+Sydney+Concord+Cancer+Centre+to+Evaluate+MN-166+%28ibudilast%29+in+Chemotherapy-Induced+Peripheral+Neuropathy/13996801.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Collaboration+with+the+University+of+Sydney+Concord+Cancer+Centre+to+Evaluate+MN-166+%28ibudilast%29+in+Chemotherapy-Induced+Peripheral+Neuropathy/13996801.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Collaboration+with+the+University+of+Sydney+Concord+Cancer+Centre+to+Evaluate+MN-166+%28ibudilast%29+in+Chemotherapy-Induced+Peripheral+Neuropathy/13996801.html</guid>
   <pubDate>Wed, 28 Mar 2018 19:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20576704</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39429199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Collaboration with the University of Sydney Concord Cancer Centre to Evaluate MN-166 (ibudilast) in Chemotherapy-Induced Peripheral Neuropathy</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Collaboration+with+the+University+of+Sydney+Concord+Cancer+Centre+to+Evaluate+MN-166+%28ibudilast%29+in+Chemotherapy-Induced+Peripheral+Neuropathy/13996801.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Collaboration+with+the+University+of+Sydney+Concord+Cancer+Centre+to+Evaluate+MN-166+%28ibudilast%29+in+Chemotherapy-Induced+Peripheral+Neuropathy/13996801.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Collaboration+with+the+University+of+Sydney+Concord+Cancer+Centre+to+Evaluate+MN-166+%28ibudilast%29+in+Chemotherapy-Induced+Peripheral+Neuropathy/13996801.html</guid>
   <pubDate>Wed, 28 Mar 2018 19:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20576704</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39429199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Collaboration with the University of Sydney Concord Cancer Centre to Evaluate MN-166 (ibudilast) in Chemotherapy-Induced Peripheral Neuropathy</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Collaboration+with+the+University+of+Sydney+Concord+Cancer+Centre+to+Evaluate+MN-166+%28ibudilast%29+in+Chemotherapy-Induced+Peripheral+Neuropathy/13996801.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Collaboration+with+the+University+of+Sydney+Concord+Cancer+Centre+to+Evaluate+MN-166+%28ibudilast%29+in+Chemotherapy-Induced+Peripheral+Neuropathy/13996801.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Collaboration+with+the+University+of+Sydney+Concord+Cancer+Centre+to+Evaluate+MN-166+%28ibudilast%29+in+Chemotherapy-Induced+Peripheral+Neuropathy/13996801.html</guid>
   <pubDate>Wed, 28 Mar 2018 19:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20576704</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.39429199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova to Participate in Business Development Panel Session at the BIO Asia International Conference in Tokyo</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+to+Participate+in+Business+Development+Panel+Session+at+the+BIO+Asia+International+Conference+in+Tokyo/13934589.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+to+Participate+in+Business+Development+Panel+Session+at+the+BIO+Asia+International+Conference+in+Tokyo/13934589.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+to+Participate+in+Business+Development+Panel+Session+at+the+BIO+Asia+International+Conference+in+Tokyo/13934589.html</guid>
   <pubDate>Mon, 12 Mar 2018 19:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova to Participate in Business Development Panel Session at the BIO Asia International Conference in Tokyo</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+to+Participate+in+Business+Development+Panel+Session+at+the+BIO+Asia+International+Conference+in+Tokyo/13934589.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+to+Participate+in+Business+Development+Panel+Session+at+the+BIO+Asia+International+Conference+in+Tokyo/13934589.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+to+Participate+in+Business+Development+Panel+Session+at+the+BIO+Asia+International+Conference+in+Tokyo/13934589.html</guid>
   <pubDate>Mon, 12 Mar 2018 19:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova to Present at the Cowen Health Care Conference in Boston</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+to+Present+at+the+Cowen+Health+Care+Conference+in+Boston/13860547.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+to+Present+at+the+Cowen+Health+Care+Conference+in+Boston/13860547.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+to+Present+at+the+Cowen+Health+Care+Conference+in+Boston/13860547.html</guid>
   <pubDate>Sun, 25 Feb 2018 18:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19454022</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova to Present at the Cowen Health Care Conference in Boston</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+to+Present+at+the+Cowen+Health+Care+Conference+in+Boston/13860547.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+to+Present+at+the+Cowen+Health+Care+Conference+in+Boston/13860547.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+to+Present+at+the+Cowen+Health+Care+Conference+in+Boston/13860547.html</guid>
   <pubDate>Sun, 25 Feb 2018 18:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19454022</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova to Present at the Cowen Health Care Conference in Boston</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+to+Present+at+the+Cowen+Health+Care+Conference+in+Boston/13860547.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+to+Present+at+the+Cowen+Health+Care+Conference+in+Boston/13860547.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+to+Present+at+the+Cowen+Health+Care+Conference+in+Boston/13860547.html</guid>
   <pubDate>Sun, 25 Feb 2018 18:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19454022</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Upcoming Presentation of the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS at the American Academy of Neurology (AAN) 70th Annual Meeting in Los Angeles, Califo</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Upcoming+Presentation+of+the+SPRINT-MS+Phase+2b+Trial+of+MN-166+%28ibudilast%29+in+Progressive+MS+at+the+American+Academy+of+Neurology+%28AAN%29+70th+Annual+Meeting+in+Los+Angeles%2C+Califo/13834548.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Upcoming+Presentation+of+the+SPRINT-MS+Phase+2b+Trial+of+MN-166+%28ibudilast%29+in+Progressive+MS+at+the+American+Academy+of+Neurology+%28AAN%29+70th+Annual+Meeting+in+Los+Angeles%2C+Califo/13834548.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Upcoming+Presentation+of+the+SPRINT-MS+Phase+2b+Trial+of+MN-166+%28ibudilast%29+in+Progressive+MS+at+the+American+Academy+of+Neurology+%28AAN%29+70th+Annual+Meeting+in+Los+Angeles%2C+Califo/13834548.html</guid>
   <pubDate>Sun, 18 Feb 2018 18:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41533557</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Upcoming Presentation of the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS at the American Academy of Neurology (AAN) 70th Annual Meeting in Los Angeles, Califo</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Upcoming+Presentation+of+the+SPRINT-MS+Phase+2b+Trial+of+MN-166+%28ibudilast%29+in+Progressive+MS+at+the+American+Academy+of+Neurology+%28AAN%29+70th+Annual+Meeting+in+Los+Angeles%2C+Califo/13834548.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Upcoming+Presentation+of+the+SPRINT-MS+Phase+2b+Trial+of+MN-166+%28ibudilast%29+in+Progressive+MS+at+the+American+Academy+of+Neurology+%28AAN%29+70th+Annual+Meeting+in+Los+Angeles%2C+Califo/13834548.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Upcoming+Presentation+of+the+SPRINT-MS+Phase+2b+Trial+of+MN-166+%28ibudilast%29+in+Progressive+MS+at+the+American+Academy+of+Neurology+%28AAN%29+70th+Annual+Meeting+in+Los+Angeles%2C+Califo/13834548.html</guid>
   <pubDate>Sun, 18 Feb 2018 18:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41533557</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Upcoming Presentation of the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS at the American Academy of Neurology (AAN) 70th Annual Meeting in Los Angeles, Califo</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Upcoming+Presentation+of+the+SPRINT-MS+Phase+2b+Trial+of+MN-166+%28ibudilast%29+in+Progressive+MS+at+the+American+Academy+of+Neurology+%28AAN%29+70th+Annual+Meeting+in+Los+Angeles%2C+Califo/13834548.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Upcoming+Presentation+of+the+SPRINT-MS+Phase+2b+Trial+of+MN-166+%28ibudilast%29+in+Progressive+MS+at+the+American+Academy+of+Neurology+%28AAN%29+70th+Annual+Meeting+in+Los+Angeles%2C+Califo/13834548.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Upcoming+Presentation+of+the+SPRINT-MS+Phase+2b+Trial+of+MN-166+%28ibudilast%29+in+Progressive+MS+at+the+American+Academy+of+Neurology+%28AAN%29+70th+Annual+Meeting+in+Los+Angeles%2C+Califo/13834548.html</guid>
   <pubDate>Sun, 18 Feb 2018 18:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41533557</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Upcoming Presentation of the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS at the American Academy of Neurology (AAN) 70th Annual Meeting in Los Angeles, Califo</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Upcoming+Presentation+of+the+SPRINT-MS+Phase+2b+Trial+of+MN-166+%28ibudilast%29+in+Progressive+MS+at+the+American+Academy+of+Neurology+%28AAN%29+70th+Annual+Meeting+in+Los+Angeles%2C+Califo/13834548.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Upcoming+Presentation+of+the+SPRINT-MS+Phase+2b+Trial+of+MN-166+%28ibudilast%29+in+Progressive+MS+at+the+American+Academy+of+Neurology+%28AAN%29+70th+Annual+Meeting+in+Los+Angeles%2C+Califo/13834548.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Upcoming+Presentation+of+the+SPRINT-MS+Phase+2b+Trial+of+MN-166+%28ibudilast%29+in+Progressive+MS+at+the+American+Academy+of+Neurology+%28AAN%29+70th+Annual+Meeting+in+Los+Angeles%2C+Califo/13834548.html</guid>
   <pubDate>Sun, 18 Feb 2018 18:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41533557</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Closing of Underwritten Public Offering of Common Stock</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Closing+of+Underwritten+Public+Offering+of+Common+Stock/13801139.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Closing+of+Underwritten+Public+Offering+of+Common+Stock/13801139.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Closing+of+Underwritten+Public+Offering+of+Common+Stock/13801139.html</guid>
   <pubDate>Mon, 12 Feb 2018 18:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28871445</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Closing of Underwritten Public Offering of Common Stock</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Closing+of+Underwritten+Public+Offering+of+Common+Stock/13801139.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Closing+of+Underwritten+Public+Offering+of+Common+Stock/13801139.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Closing+of+Underwritten+Public+Offering+of+Common+Stock/13801139.html</guid>
   <pubDate>Mon, 12 Feb 2018 18:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28871445</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Closing of Underwritten Public Offering of Common Stock</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Closing+of+Underwritten+Public+Offering+of+Common+Stock/13801139.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Closing+of+Underwritten+Public+Offering+of+Common+Stock/13801139.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Closing+of+Underwritten+Public+Offering+of+Common+Stock/13801139.html</guid>
   <pubDate>Mon, 12 Feb 2018 18:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28871445</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Closing of Underwritten Public Offering of Common Stock</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Closing+of+Underwritten+Public+Offering+of+Common+Stock/13801139.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Closing+of+Underwritten+Public+Offering+of+Common+Stock/13801139.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Closing+of+Underwritten+Public+Offering+of+Common+Stock/13801139.html</guid>
   <pubDate>Mon, 12 Feb 2018 18:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28871445</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Pricing of Underwritten Public Offering of Common Stock</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Pricing+of+Underwritten+Public+Offering+of+Common+Stock/13779405.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Pricing+of+Underwritten+Public+Offering+of+Common+Stock/13779405.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Pricing+of+Underwritten+Public+Offering+of+Common+Stock/13779405.html</guid>
   <pubDate>Wed, 07 Feb 2018 19:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28871445</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Pricing of Underwritten Public Offering of Common Stock</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Pricing+of+Underwritten+Public+Offering+of+Common+Stock/13779405.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Pricing+of+Underwritten+Public+Offering+of+Common+Stock/13779405.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Pricing+of+Underwritten+Public+Offering+of+Common+Stock/13779405.html</guid>
   <pubDate>Wed, 07 Feb 2018 19:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28871445</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Pricing of Underwritten Public Offering of Common Stock</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Pricing+of+Underwritten+Public+Offering+of+Common+Stock/13779405.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Pricing+of+Underwritten+Public+Offering+of+Common+Stock/13779405.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Pricing+of+Underwritten+Public+Offering+of+Common+Stock/13779405.html</guid>
   <pubDate>Wed, 07 Feb 2018 19:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28871445</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Proposed Underwritten Public Offering of Common Stock</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Proposed+Underwritten+Public+Offering+of+Common+Stock/13777778.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Proposed+Underwritten+Public+Offering+of+Common+Stock/13777778.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Proposed+Underwritten+Public+Offering+of+Common+Stock/13777778.html</guid>
   <pubDate>Wed, 07 Feb 2018 16:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28871445</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
  <item>
   <title>MediciNova Announces Proposed Underwritten Public Offering of Common Stock</title>
   <link>http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Proposed+Underwritten+Public+Offering+of+Common+Stock/13777778.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Proposed+Underwritten+Public+Offering+of+Common+Stock/13777778.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediciNova+Announces+Proposed+Underwritten+Public+Offering+of+Common+Stock/13777778.html</guid>
   <pubDate>Wed, 07 Feb 2018 16:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">4875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28871445</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MNOV</category>
   	  </item>
 </channel>
</rss>
